Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.32%
Monthly Change
-5.40%
6 month change
-25.87%
Year Change
+104.11%
Previous Close
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Volume
21
Markets
US Stock Market
Healthcare
GALT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
57.16 M
59.36 M
59.44 M
61.9 M
63.18 M
—
Valuation ratios
Enterprise value
101.41 M
83.75 M
52.06 M
82.55 M
66.88 M
521.06 M
Price to earnings ratio
—
-3.98
-1.82
-2.35
-1.7
-13.87
Price to sales ratio
—
877.9
125.82
242.31
136.7
146.11
Price to cash flow ratio
—
-4.98
-2.26
-3.18
-1.92
-16.37
Price to book ratio
—
331.01
-2.04
-1.68
-0.76
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.79
0.73
1.82
1.46
2.69
2.81
Return on equity %
1.04
34.18
1.14
0.66
0.45
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
21.87 K
6 885.46
8 812.96
7 216.5
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
22.12 K
6 961.58
9 506.02
8 001.19
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.46
4.63
1.58
1.77
0.49
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
0.02
0.02
0.03
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
0.42
0.52
0.55
0.67
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.68
0.31
0.43
0.24
0.76
Net current asset value per share
—
0.71
0.35
0.46
0.28
0.87
Tangible book value per share
—
0.01
0.56
1.02
1.67
7.28
Working capital per share
—
0.56
0.13
0.2
-0.29
-3.75
Book value per share
—
0.01
0.56
1.02
1.67
7.28
News
Galectin Therapeutics director Marc Rubin resigns from board
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA provides feedback on Galectin’s belapectin development program
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT)
Galectin Therapeutics Stock: NAVIGATE Data Validates The Fibrosis Thesis (NASDAQ:GALT)
Belapectin shows promising antifibrotic effects in MASH patients
10x fund sells Galectin Therapeutics (GALT) shares for $246,800
Tesla, Google lead market cap stock movers on Monday
Galectin Therapeutics Inc. (GALT) Is Up 7.48% in One Week: What You Should Know